Biogen and Elan file for Tysabri first line use in MS
January 18, 2013Sales and Marketing Biogen IDEC, EMA, Elan, FDA, MS, Tsyabri, gilenya
Biogen Idec and Elan have applied to the FDA and EMA to expand Tysabri’s use in patients with relapsing forms …
MPs: ‘get on with VBP’
January 18, 2013Medical Communications, Sales and Marketing NHS, NICE, PPRS, VBP
An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …
Senior sales appointment at Rieke Dispensing
January 18, 2013Manufacturing and Production, Research and Development, Sales and Marketing Nicolas Lemaigre-Voreaux, Rieke Dispensing
Packaging firm Rieke Dispensing has appointed Nicolas Lemaigre-Voreaux as its European Sales director to spearhead the company’s growth programme. Lemaigre-Voreaux …
Go digital health launched
January 17, 2013Medical Communications GolinHarris, Virgo, go digital health
A new global digital practice, go digital health, has been launched by Virgo Health and GolinHarris. The team brings together …
EMA issues draft guidance on shared facility risks
January 17, 2013Manufacturing and Production EMA, manufacturing
The European Medicines Agency has issued draft guidance to help drug manufacturers avoid cross-contamination of products made in shared facilities. …
Bayer cleared of Xarelto ‘breaches’
January 17, 2013Medical Communications, Sales and Marketing Bayer, PMCPA, Xarelto
Bayer has been found not guilty of making multiple breaches of the ABPI Code of Practice following an anonymous complaint …
Scotland fund for rare diseases
January 17, 2013Sales and Marketing SMC, Scotland, rare diseases
The Scottish government is launching a £21 million fund in March to meet the costs of patients who require orphan …
MSI appoints senior consultant
January 17, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Watson, MSI Consultancy
Strategic pharma marketing consultancy firm The MSI Consultancy has appointed David Watson as a senior consultant, specialising in channel strategy. …
Private equity firm pays $212m for Cambridge Major Labs
January 16, 2013Manufacturing and Production American Capital, CML, Cambridge
Private equity firm American Capital has said it will pay $212 million to buy out Cambridge Major Laboratories (CML), a …
The price of innovation
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, NICE, Rose, VBP
One of the strange paradoxes of our industry is that we have a very large number of new medicines in …
AstraZeneca shakes up management
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mackay, R&D, Soriot
AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …
Sanofi Pasteur MSD appoint president of Vaccines Europe
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrea Rappagliosi, Sanofi pasteur msd, vaccines
Vice president of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Andrea Rappagliosi has been appointed president …
Boehringer in oncology tie-up
January 16, 2013Research and Development, Sales and Marketing Boehringer, Cancer, horizon, x-man
Boehringer Ingelheim has entered a five-year tie-up with a UK biotech company which specialises in helping research into personalised medicines. …
NICE consults on tamoxifen
January 15, 2013Sales and Marketing Cancer, Evista, NICE, lilly, tamoxifen
Patient groups have welcomed NICE’s new draft guideline recommending the use of preventive treatments in women who have a family …
Mitsubishi deal to buy Qualicaps will close in March
January 15, 2013Manufacturing and Production Mitsubishi, Patheon, Qualicaps
Mitsubishi Chemical has agreed to buy Qualicaps from US private equity company Carlyle Group in the latest round of M&A …
Zytiga extended in EU
January 15, 2013Sales and Marketing EU, J&J, JJ, Janssen, Zytiga
Janssen is celebrating the European Commission’s decision to extend the licence for its prostate cancer treatment Zytiga. The once-daily pill …
Pharma manufacturing news in brief
January 14, 2013Manufacturing and Production ADMA, Biotest, Catalent, Emerson, Nanocarrier, Orient Europharma, UCB
Facility news from Orient Europharma/NanoCarrier, Catalent and China Biologic, plus new contracts for Emerson Process Management and Biotest Pharma.
FDA publishes guidance on abuse-resistant opioids
January 14, 2013Manufacturing and Production CDC, FDA, hamburg, opioids
The US Food and Drug Administration has issued draft guidance designed to combat the escalating problem of abuse of prescription …
Lonza earmarks $15m for ADC plant expansion
January 14, 2013Manufacturing and Production ADC, API, Lonza, Novasep
Swiss contract manufacturer Lonza has said it will invest around 14 million francs ($15m) in new capacity for antibody drug …
Kathryn Gallant joins Insight Health US as joint chief executive
January 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gallant, insight health
The former managing partner for US health at Hall & Partners has joined the consultancy firm Insight Health US as …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
